- Lobbying
- Stephen AND Conafay
Lobbying Arrangements Results for 'Stephen Conafay'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Manufacturing facilities |
The Conafay Group, LLC on behalf of Medicago
|
The Conafay Group, L.L.C. | |||
Details Appropriate funds for pharmaceutical research and development. |
Banner Life Sciences
|
The Conafay Group, L.L.C. | |||
Details Incentives for antibiotic innovation |
MEDICIS PHARMACEUTICAL CORPORATION
|
Fabiani & Company | |||
Details H.R. 6 - 21st Century Cures Act Developing a range of tissue and disease models for medical research and therapeutics applications. |
Organovo, Inc.
|
The Conafay Group, L.L.C. | |||
Details 21st Century Cures legislation. |
WCG WIRB Copernicus Group
|
The Conafay Group, L.L.C. | |||
Details Seeking support for rabies research. |
Mid-Atlantic BioTherapeutics
|
The Conafay Group, L.L.C. | |||
Details Advocating for medical research. |
Dova Pharmaceuticals
|
The Conafay Group, LLC | |||
Details Advocacy for medical research. |
Chiesi USA, Inc.
|
The Conafay Group, LLC | |||
Details Support for research on viral diseases |
Cidara Therapeutics, Inc.
|
The Conafay Group, LLC | |||
Details FDA Reform Medicare policies involving antibiotics to treat resistant pathogens. |
Cempra Pharmaceuticals
|
The Conafay Group, L.L.C. | |||
Details Educate Members of Congress, their staff, and key Congressional committees about policy changes needed with Medicare. |
Durata Therapeutics, Inc.
|
The Conafay Group, L.L.C. | |||
Details Legislative initiatives relating to the GAIN Act and associated legislation, federal funding of biotechnology by the DoD, DHHS, NSF, and other similar agencies. |
Cary Pharmaceuticals
|
The Conafay Group, L.L.C. | |||
Details support medical disease research. |
Lysovant Sciences Inc.
|
The Conafay Group, LLC | |||
Details Medical Technology |
Innotech USA, Inc.
Aesthetics lasers |
FABIANI & COMPANY, LLC | |||
Details Appropriations |
Advanced Liquid Logic
Micro Fluidics |
FABIANI & COMPANY, LLC | |||
Details H.R. 6 21st Century Cures Act Creation of comparative oncology Center of Excellence within the Food and Drug Administration |
Woodberry & Associates on behalf of Colorado State University Foundation
|
The Conafay Group, L.L.C. | |||
Details Abuse deterrent formulations of pharmaceutical products |
TRF Coalition
|
Fabiani & Company | |||
Details Federal funding for research and development |
ALNYLAM PHARMACEUTICALS
|
Fabiani & Company | |||
Details General legislation pertaining to the improvement of the healthcare system to provide access to Medicare and Medicaid; PDUFA Reauthorization. General legislation pertaining to the improvement of th... |
Alnylam Pharmaceuticals, Inc.
|
The Conafay Group, L.L.C. | |||
Details US pharmaceutical manufacturing |
Phlow Corporation
|
The Conafay Group, LLC | |||
Details Education & advocacy for mechanisms to spur development of clinical trials. |
Foundation Fighting Blindness
|
The Conafay Group, LLC | |||
Details Defense Appropriations RDT&E |
BrainCells, Inc.
|
Fabiani & Company | |||
Details FY12 Department of Defense Appropriations Act and Authorization Act, provisions relating to research and development of military robotics |
VISION ROBOTICS
|
Fabiani & Company | |||
Details FY12 National Defense Authorization Act FY12 Defense Appropriations Bill |
Otonomy Corporation
|
Fabiani & Company | |||
Details Defense appropriations RDT&E |
Akesis Pharmaceuticals Inc.
|
Fabiani & Company | |||
Details Defense Policy, production of field programmable gate arrays |
Achronix Semiconductor Corporation
|
Fabiani & Company | |||
Details Department of Defense Appropriations Act of 2009, provisions relating to Army funding for medical research Department of Defense Appropriations Act of 2009, provisions relating to funding for novel... |
VAXINNATE
|
Fabiani & Company | |||
Details Support for medical/disease research. |
Atea Pharmaceuticals, Inc.
|
The Conafay Group, LLC | |||
Details Health Reform |
Lundbeck Research USA, Inc.
|
Fabiani & Company | |||
Details Lobbied for antibiotics legislation |
Tetraphase Pharmaceuticals
|
Fabiani & Company | |||
Details Patent extension/restoration |
The Medicines Company
Pharmaceuticals company that develpos acute care products for hospitals |
Fabiani & Company | |||
Details Educating Congressional representatives on issues surrounding the Generic User Fee legislation (GDUFA) |
Patheon Pharmaceuticals Services Inc.
|
Fabiani & Company | |||
Details Legislation related to antimicrobial resistance(AMR), reimbursement reform, the PASTEUR Act, Cares Act 2.0 and FY24 Appropriations and PAHPA. |
The Conafay Group on behalf of Antibiotics Working Group
|
The Conafay Group, L.L.C. | |||
Details Funding for drug development; sample procurement Funding for drug development |
Cempra Pharmaceuticals Inc.
|
Fabiani & Company | |||
Details Educating Members of Congress on the challenges of bringing innovative medical devices to market. |
MEDRAD, INC
|
Fabiani & Company | |||
Details Procurement of novel antibiotic. |
Paratek Pharmaceuticals, Inc.
|
The Conafay Group, LLC | |||
Details Educating Congressional Members and staff on the need to encourage FDA to be less conservative in regulating rare cancer drugs and to support accelerated rare cancer therapeuticss approval. |
Sarcoma Foundation of America
|
Fabiani & Company | |||
Details Federal funding to support development of biopharmaceutical products to treat military and civilian populations |
ARCA biopharma, Inc.
|
Fabiani & Company | |||
Details Governmnet funding and contracts related to multiplexing diagnostic device. |
PrimeraDx
|
Fabiani & Company | |||
Details Production and development of medical countermeasures, medical products Production and development of medical countermeasures, medical products. Supporting passage of the President's Budget as req... |
Nanotherapeutics, Inc.
|
Fabiani & Company | |||
Details HR 3326; FY10 Defense Appropriations Act; Army Research and Development for HIV Vaccine Research |
Spaltudaq Corporation
|
Fabiani & Company | |||
Details Department of Defense Appropriations Act of 2010, provisions relating to Department of Defense medical research (RDT&E) Department of Defense Appropriations Act of 2010, funding for biodefense prod... |
Planet Biotechnology Inc.
|
Fabiani & Company | |||
Details Pursuing government funding to support therapeutic platform development for infectious diseases |
3-V Biosciences, Inc.
Development of pharmaceuticals to address unmet needs in infectious disease |
Fabiani & Company | |||
Details Discussion with DoD Officials regarding company therapeutic's applicability to TBI and possible trials. |
Edison Pharmaceuticals
Drug development for treatment of rare mitochondrial disease, TBI, and TON |
Fabiani & Company | |||
Details Funding for biopharmaceutical product development with the Department of Defense to treat long term health impact of chronic substance abuse. Funding for biopharmaceutical product development to ad... |
Ocera Therapeutics Inc.
|
Fabiani & Company | |||
Details The Genomics and Personalized Medicine Act; Realizing the potential of personalized medicine; and Exclusive licensure of genetic associations; TRICARE reimbursement The Genomics and Personalized Me... |
Clinical Data, Inc.
|
Fabiani & Company | |||
Details |
SAP AMERICA, INC
|
FABIANI & COMPANY, LLC | |||
Details |
PURDUE PHARMA
|
FABIANI & COMPANY, LLC |